Levy Richard S's Form 4 filing
Madrigal Pharmaceuticals, Inc. (MDGL) · filed May 22, 2026
- Accession no.
- 0001628280-26-037830
- Filed
- May 22, 2026
- Trade date
- May 22, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 12 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.93M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Levy Richard SCIK 0001454983 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | Common Stock | SSaleDisposed | −40 | $506.68 | −$20,267.2 | 27,657 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −320 | $508.24 | −$162,636.8 | 27,337 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −151 | $510.36 | −$77,064.36 | 27,186 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −610 | $511.40 | −$311,954 | 26,576 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −439 | $512.50 | −$224,987.5 | 26,137 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −40 | $512.97 | −$20,518.8 | 26,097 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −343 | $514.67 | −$176,531.81 | 25,754 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −657 | $515.92 | −$338,959.44 | 25,097 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −723 | $516.87 | −$373,697.01 | 24,374 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −1,497 | $517.59 | −$774,832.23 | 22,877 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −782 | $518.76 | −$405,670.32 | 22,095 | Direct | |
| May 22, 2026 | Common Stock | SSaleDisposed | −80 | $519.98 | −$41,598.4 | 22,015 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.